Breast carcinomas occurring in young women (< 35 years) are different.

[1]  J. Bonneterre,et al.  Age as a prognostic factor in breast cancer. , 1998, Anticancer research.

[2]  J. Rodriguez-Sierra,et al.  Younger women with breast carcinoma have a poorer prognosis than older women , 1996, Cancer.

[3]  L Piana,et al.  Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features , 1995, International journal of cancer.

[4]  J. Eyfjörd,et al.  p53 abnormalities and genomic instability in primary human breast carcinomas. , 1995, Cancer research.

[5]  R. Walker,et al.  Pathological and biological features of mammographically detected invasive breast carcinomas. , 1995, British Journal of Cancer.

[6]  D. Birnbaum,et al.  p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. , 1994, British Journal of Cancer.

[7]  S. Nordling,et al.  Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. , 1993, British Journal of Cancer.

[8]  D. Barnes,et al.  Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis? , 1993, Human pathology.

[9]  B. Asselain,et al.  Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.

[10]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[11]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[12]  M. Kastan,et al.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Theillet,et al.  p53 mutations occur in aggressive breast cancer. , 1992, Cancer research.

[14]  E. Pillers.  Histological grade of breast cancer in younger women , 1992, The Lancet.

[15]  E. Kawasaki,et al.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. , 1992, Journal of the National Cancer Institute.

[16]  D. Wynford‐Thomas.  P53 in tumour pathology: Can we trust immunocytochemistry? , 1992, The Journal of pathology.

[17]  F. Berrino,et al.  Survival and age at diagnosis of breast cancer in a population-based cancer registry. , 1991, European journal of cancer.

[18]  A. Harris,et al.  c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. , 1991, British Journal of Cancer.

[19]  J. Foekens,et al.  Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. , 1989, Cancer research.

[20]  J. Varley,et al.  An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer. , 1989, British Journal of Cancer.

[21]  R. Camplejohn,et al.  Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. , 1988, British Journal of Cancer.

[22]  I Persson,et al.  The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.

[23]  W. Spanos,et al.  Breast cancer in women aged 30 and under , 1982, Cancer.

[24]  C. Silfverswärd,et al.  Carcinoma of the breast in women under 30 years of age. A clinical and histopathological study of all cases reported as carcinoma to the Swedish Cancer Registry, 1958–1968 , 1977, Cancer.

[25]  Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology. , 1995, American journal of clinical pathology.

[26]  D. Allred,et al.  Breast cancer outcome and predictors of outcome: are there age differentials? , 1994, Journal of the National Cancer Institute. Monographs.

[27]  D. Page,et al.  Pathology and heredity of breast cancer in younger women. , 1994, Journal of the National Cancer Institute. Monographs.

[28]  G. Ribeiro,et al.  The prognosis of breast carcinoma in women aged less than 40 years. , 1981, Clinical radiology.